VanEck Associates
HALO icon

VanEck Associates’s Halozyme HALO Stock Holding History

VanEck Associates’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$857K Sell
10,945
-14
-0.1% -$955 ﹤0.01% 1153
2026
Q1 		$708K Buy
10,959
+2,246
+26% +$158K ﹤0.01% 1135
2025
Q4 		$586K Buy
8,713
+415
+5% +$27.9K ﹤0.01% 1154
2025
Q3 		$609K Sell
8,298
-4,825
-37% -$321K ﹤0.01% 1159
2025
Q2 		$683K Buy
13,123
+3,018
+30% +$172K ﹤0.01% 1116
2025
Q1 		$645K Sell
10,105
-1,005
-9% -$58.4K ﹤0.01% 1109
2024
Q4 		$531K Sell
11,110
-506
-4% -$25.9K ﹤0.01% 1125
2024
Q3 		$590K Sell
11,616
-6,401
-36% -$367K ﹤0.01% 1069
2024
Q2 		$943K Sell
18,017
-320
-2% -$14K ﹤0.01% 999
2024
Q1 		$746K Sell
18,337
-25
-0.1% -$937 ﹤0.01% 1015
2023
Q4 		$679K Sell
18,362
-3,115
-15% -$117K ﹤0.01% 1011
2023
Q3 		$820K Buy
21,477
+654
+3% +$26.8K ﹤0.01% 938
2023
Q2 		$751K Sell
20,823
-2,160
-9% -$73.7K ﹤0.01% 932
2023
Q1 		$878K Sell
22,983
-1,194
-5% -$56K ﹤0.01% 859
2022
Q4 		$1.38M Sell
24,177
-691
-3% -$35.4K ﹤0.01% 740
2022
Q3 		$983K Sell
24,868
-6,124
-20% -$271K ﹤0.01% 776
2022
Q2 		$1.36M Sell
30,992
-3,449
-10% -$149K ﹤0.01% 736
2022
Q1 		$1.37M Buy
+34,441
New +$1.23M ﹤0.01% 779
2017
Q1 		– Sell
-1,565
Closed -$15K – 893
2016
Q4 		$15K Buy
1,565
+773
+98% +$8.47K ﹤0.01% 873
2016
Q3 		$10K Sell
792
-216
-21% -$2.21K ﹤0.01% 860
2016
Q2 		$9K Buy
1,008
+97
+11% +$957 ﹤0.01% 847
2016
Q1 		$9K Buy
+911
New +$8.57K ﹤0.01% 812

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

VanEck Associates's HALO Position: Q2 2026 in Review

VanEck Associates reduced its Halozyme (HALO) stake by 0.13% in Q2 2026, selling an estimated $955 and leaving 10,945 shares worth $857K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

VanEck Associates first reported a position in HALO in Q1 2016 and has held it in 22 quarters since. The position peaked at $1.38M in Q4 2022. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • VanEck Associates held 10,945 shares of Halozyme worth $857K as of Q2 2026.
  • VanEck Associates sold 14 Halozyme shares in Q2 2026, an estimated $955.
  • Halozyme made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1153 holding.
  • VanEck Associates first reported a position in Halozyme in Q1 2016 and has held it in 22 quarters since.
  • VanEck Associates's Halozyme position peaked at $1.38M in Q4 2022.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.